What is the clinical evidence from this study?

Population: exercise induced cardiovascular remodeling. Intervention: Dapagliflozin and exercise vs. controls. Primary outcome: cardiac morphology, sarcomeric function, and proteomic alterations.

What does this research mean for the field?

Dapagliflozin combined with exercise enhances systolic and mechanoenergetic function without altering exercise-induced physiological myocardial hypertrophy. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to understand how dapagliflozin and exercise together affect heart structure and function in rats.

June 12, 2026European Journal of Preventive CardiologyOpen Access

Interaction of dapagliflozin and exercise in a small animal model: functional, sarcomeric, and proteomic insights

View Full Paper

Ask AI

Bookmark

Key result

Dapagliflozin plus exercise enhances systolic and mechanoenergetic responses in rats without affecting physiological myocardial hypertrophy.

Why the study?

Dapagliflozin is a key therapy for heart failure, but its interaction with exercise-induced cardiovascular remodeling remains unclear.

Does dapagliflozin combined with exercise improve cardiac morphology and sarcomeric function in a rat model of exercise-induced cardiovascular remodeling?

Key Points

This research aims to understand how dapagliflozin and exercise together affect heart structure and function in rats.
Male Wistar rats were divided into four groups: controls, exercised, Dapa-treated, and exercised+Dapa.
Rats underwent 12 weeks of swim training with daily dapagliflozin administration (1 mg/kg).
Left ventricular function was analyzed via echocardiography, cardiomyocyte force generation, and proteomic profiling.
Exercise improved physiological hypertrophy and systolic function without affecting heart mass.
Combined exercise and dapagliflozin treatment enhanced contractility and force generation in cardiomyocytes.
Proteomics identified significant changes in proteins related to metabolism, redox regulation, and cardiovascular signaling.

Structured PICO

Does dapagliflozin combined with exercise improve cardiac morphology and sarcomeric function in a rat model of exercise-induced cardiovascular remodeling?

Population

Male Wistar rats assigned to control, exercise, dapagliflozin, or combined groups for 12 weeks.

Intervention

Dapagliflozin (1 mg/kg daily) combined with 12 weeks of swim training

Comparator

Controls (no exercise, no dapagliflozin), exercise alone, and dapagliflozin alone

Outcome

Cardiac morphology, sarcomeric function, and proteomic alterationssurrogate

Dapagliflozin and exercise induce distinct but complementary molecular adaptations that synergistically enhance systolic function and sarcomeric performance in a rat model.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support combined dapagliflozin-exercise strategies in HF models; leaves open clinical translation from rat data.

Cite This Study

Kolodziejska et al. (2026) studied exercise induced cardiovascular remodeling. Dapagliflozin and exercise vs. controls was evaluated on cardiac morphology, sarcomeric function, and proteomic alterations. Dapagliflozin combined with 12 weeks of exercise in male rats enhanced systolic and mechanoenergetic response without affecting exercise-induced physiological myocardial hypertrophy.

synapsesocial.com/papers/6a2bd11d6550ea4541ffe892 https://doi.org/10.1093/eurjpc/zwag249.380

Topics

SGLT2 inhibitors in heart failure

View Full Paper

Ask AI

Bookmark

Interaction of dapagliflozin and exercise in a small animal model: functional, sarcomeric, and proteomic insights

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Interaction of dapagliflozin and exercise in a small animal model: functional, sarcomeric, and proteomic insights

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider